Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up
2016 ◽
Vol 48
(5)
◽
pp. 817-818
◽
2010 ◽
Vol 47
(7-8)
◽
pp. 1585-1591
◽
2000 ◽
Vol 66
(5)
◽
pp. 1721-1722
◽
2016 ◽
Vol 13
(12)
◽
pp. 1209
◽